Dopamine D1-Like Receptor-Mediated Insurmountable Blockade of the Reinforcing Effects of Cocaine in Rats.

IF 3.1 3区 医学 Q2 PHARMACOLOGY & PHARMACY Journal of Pharmacology and Experimental Therapeutics Pub Date : 2024-10-23 DOI:10.1124/jpet.124.002362
Takato Hiranita, Paul L Soto, Jonathan L Katz
{"title":"Dopamine D<sub>1</sub>-Like Receptor-Mediated Insurmountable Blockade of the Reinforcing Effects of Cocaine in Rats.","authors":"Takato Hiranita, Paul L Soto, Jonathan L Katz","doi":"10.1124/jpet.124.002362","DOIUrl":null,"url":null,"abstract":"<p><p>Previous studies indicated differing effects of dopamine D<sub>1</sub>-like and D<sub>2</sub>-like receptor (D<sub>1</sub>R and D<sub>2</sub>R, respectively) agonists on cocaine self-administration. Leftward shifts by D<sub>2</sub>R agonists in the cocaine self-administration dose-effect function contrast with decreases by D<sub>1</sub>R agonists in maximal cocaine self-administration without rightward or leftward displacement. Whether the effects of the D<sub>1</sub>R agonists are due to actions at D<sub>1</sub>Rs has not been determined possibly due to the difficulty in separating the blockade by a D<sub>1</sub>R antagonist of the effects of the D<sub>1</sub>R agonists and those of cocaine. In the present study, pretreatment with the D<sub>1</sub>R agonists <i>R</i>(+)-SKF-81297 (0.1-1.0 mg/kg) and ({plus minus})-SKF-82958 (0.032-0.32 mg/kg) dose-dependently decreased maximal cocaine self-administration at doses below those affecting food-reinforced responding. In contrast, pretreatment with the D<sub>2</sub>R agonists <i>R</i>(-)-NPA (0.001-0.01 mg/kg) and (-)-quinpirole (0.01-0.1 mg/kg) dose-dependently left shifted the cocaine self-administration dose-effect function. The decreases by D<sub>1</sub>R agonists in maximal cocaine self-administration were dose-dependently antagonized by the D<sub>1</sub>R antagonist SCH-39166 at doses that alone had no effects on cocaine self-administration. Doses of SCH-39166 that blocked the effects of the D<sub>1</sub>R agonists on cocaine self-administration were like those that shifted self-administration of D<sub>1</sub>R agonists to the right but had no effects on self-administration of D<sub>2</sub>R agonists. Self-administration of the D<sub>2</sub>R agonists was dose-dependently shifted to the right by the preferential D<sub>2</sub>R antagonist, L-741,626, but not by SCH-39166. These results demonstrate that the decreases by the D<sub>1</sub>R agonists in cocaine self-administration are selectively D<sub>1</sub>R-mediated, and support findings suggesting fundamentally distinct roles of the D<sub>1</sub>Rs and D<sub>2</sub>Rs in cocaine reinforcement. <b>Significance Statement</b> Dopamine D<sub>1</sub>-like (D<sub>1</sub>R) agonists decrease maximal cocaine self-administration, whereas D<sub>2</sub>-like (D<sub>2</sub>R) agonists shift the cocaine self-administration dose-effect function leftward with mechanisms for those different effects unclear. The present study demonstrates blockade by the selective D<sub>1</sub>R antagonist SCH-39166 of decreases in maximal cocaine self-administration at doses that blocked other D<sub>1</sub>R-mediated effects but not effects of cocaine, suggesting fundamentally distinct roles of the dopamine D<sub>1</sub>-like and D<sub>2</sub>-like receptors in cocaine reinforcement and development of D<sub>1</sub>R agonists as potential treatments for cocaine-use disorder.</p>","PeriodicalId":16798,"journal":{"name":"Journal of Pharmacology and Experimental Therapeutics","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacology and Experimental Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1124/jpet.124.002362","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Previous studies indicated differing effects of dopamine D1-like and D2-like receptor (D1R and D2R, respectively) agonists on cocaine self-administration. Leftward shifts by D2R agonists in the cocaine self-administration dose-effect function contrast with decreases by D1R agonists in maximal cocaine self-administration without rightward or leftward displacement. Whether the effects of the D1R agonists are due to actions at D1Rs has not been determined possibly due to the difficulty in separating the blockade by a D1R antagonist of the effects of the D1R agonists and those of cocaine. In the present study, pretreatment with the D1R agonists R(+)-SKF-81297 (0.1-1.0 mg/kg) and ({plus minus})-SKF-82958 (0.032-0.32 mg/kg) dose-dependently decreased maximal cocaine self-administration at doses below those affecting food-reinforced responding. In contrast, pretreatment with the D2R agonists R(-)-NPA (0.001-0.01 mg/kg) and (-)-quinpirole (0.01-0.1 mg/kg) dose-dependently left shifted the cocaine self-administration dose-effect function. The decreases by D1R agonists in maximal cocaine self-administration were dose-dependently antagonized by the D1R antagonist SCH-39166 at doses that alone had no effects on cocaine self-administration. Doses of SCH-39166 that blocked the effects of the D1R agonists on cocaine self-administration were like those that shifted self-administration of D1R agonists to the right but had no effects on self-administration of D2R agonists. Self-administration of the D2R agonists was dose-dependently shifted to the right by the preferential D2R antagonist, L-741,626, but not by SCH-39166. These results demonstrate that the decreases by the D1R agonists in cocaine self-administration are selectively D1R-mediated, and support findings suggesting fundamentally distinct roles of the D1Rs and D2Rs in cocaine reinforcement. Significance Statement Dopamine D1-like (D1R) agonists decrease maximal cocaine self-administration, whereas D2-like (D2R) agonists shift the cocaine self-administration dose-effect function leftward with mechanisms for those different effects unclear. The present study demonstrates blockade by the selective D1R antagonist SCH-39166 of decreases in maximal cocaine self-administration at doses that blocked other D1R-mediated effects but not effects of cocaine, suggesting fundamentally distinct roles of the dopamine D1-like and D2-like receptors in cocaine reinforcement and development of D1R agonists as potential treatments for cocaine-use disorder.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多巴胺 D1 类受体介导的对大鼠可卡因强化效应的不可逾越的阻断作用
以往的研究表明,多巴胺D1样受体和D2样受体(分别为D1R和D2R)激动剂对可卡因自我给药的影响不同。D2R受体激动剂在可卡因自我给药剂量效应函数中的左移与D1R受体激动剂在最大可卡因自我给药剂量效应函数中的下降形成鲜明对比,前者没有右移或左移。D1R 激动剂的作用是否是由于 D1R 的作用还没有确定,这可能是由于 D1R 拮抗剂难以将 D1R 激动剂的作用与可卡因的作用分开。在本研究中,用D1R激动剂R(+)-SKF-81297(0.1-1.0 mg/kg)和({加减})-SKF-82958(0.032-0.32 mg/kg)进行剂量依赖性预处理,在低于影响食物强迫反应的剂量时,可减少最大可卡因自我给药。相比之下,D2R激动剂R(-)-NPA(0.001-0.01 mg/kg)和(-)-喹吡酮(0.01-0.1 mg/kg)剂量依赖性地左移了可卡因自我给药剂量效应函数。D1R激动剂对最大可卡因自我摄取量的降低在剂量上依赖于D1R拮抗剂SCH-39166的拮抗作用,而SCH-39166本身对可卡因自我摄取量没有影响。阻断 D1R 激动剂对可卡因自我给药的影响的 SCH-39166 剂量与那些使 D1R 激动剂的自我给药向右移动但对 D2R 激动剂的自我给药没有影响的剂量相似。D2R 激动剂的自我给药受 D2R 首选拮抗剂 L-741,626 的影响,呈剂量依赖性右移,但不受 SCH-39166 的影响。这些结果表明,D1R 激动剂对可卡因自我给药的降低是选择性地由 D1R 介导的,并支持了 D1R 和 D2R 在可卡因强化中发挥着根本不同作用的研究结果。意义声明 多巴胺 D1 类(D1R)激动剂会降低最大可卡因自我给药量,而 D2 类(D2R)激动剂则会使可卡因自我给药剂量-效应函数向左移动,这些不同效应的机制尚不清楚。本研究表明,选择性D1R拮抗剂SCH-39166可阻断最大可卡因自我给药量的减少,而阻断其他D1R介导的效应却不能阻断可卡因的效应,这表明多巴胺D1样受体和D2样受体在可卡因强化中起着根本不同的作用,D1R激动剂有望成为治疗可卡因使用障碍的药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.90
自引率
0.00%
发文量
115
审稿时长
1 months
期刊介绍: A leading research journal in the field of pharmacology published since 1909, JPET provides broad coverage of all aspects of the interactions of chemicals with biological systems, including autonomic, behavioral, cardiovascular, cellular, clinical, developmental, gastrointestinal, immuno-, neuro-, pulmonary, and renal pharmacology, as well as analgesics, drug abuse, metabolism and disposition, chemotherapy, and toxicology.
期刊最新文献
Preclinical Evaluation of MK-8189: A Novel Phosphodiesterase 10A Inhibitor for the Treatment of Schizophrenia. Molecular mechanisms underlying amyloid beta peptide mediated upregulation of vascular cell adhesion molecule-1 in Alzheimer's disease. Clinical Development of the GluN2B-selective NMDA Receptor Inhibitor NP10679 for the Treatment of Neurologic Deficit after Subarachnoid Hemorrhage. The Influence of the Estrous Cycle on Neuropeptide S Receptor-Mediated Behaviors. Dopamine D1-Like Receptor-Mediated Insurmountable Blockade of the Reinforcing Effects of Cocaine in Rats.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1